Schedule 13D ownership disclosure

ADIAL PHARMACEUTICALS INC

Security class unavailable · CUSIP: 00688A106

Event date: 2020-12-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-20-042166
Form type
SC 13D/A
Filer
ADIAL PHARMACEUTICALS, INC.
CIK
CIK 1513525
Filed
Dec 11, 2020
Reporting period
Dec 07, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub